215.95MMarket Cap-1.15P/E (TTM)
2.650High2.440Low6.22KVolume2.650Open2.530Pre Close15.56KTurnover0.03%Turnover RatioLossP/E (Static)87.08MShares4.75052wk High-2.61P/B61.17MFloat Cap1.53052wk Low--Dividend TTM24.66MShs Float19.064Historical High--Div YieldTTM8.30%Amplitude1.530Historical Low2.503Avg Price1Lot Size
Inventiva Stock Forum
Benzinga· 3 mins ago
The Data Monitoring Committee recommended to continue the clinical trial without modification of the current protocol, based on the pre-planned review of safety data.
The recommendation was based on the unblinded review by the DMC of safety data from more than 1000 patients randomized in the main and exploratory cohorts,...
Big buyout of the stocks?
MT Newswires· 5 mins ago
Inventiva (IVA.PA) secured new financing primarily earmarked for the phase 3 trial of its lanifibranor treatment for metabolic dysfunction-associated steatohepatitis, a fatty liver disease and its subsequent marketing approval and commercialization.
The clinical-stage biopharmaceutical company secured an immediate financing of 94.1 million euros worth of shares and ...
Benzinga·
The Data Monitoring Committee recommended to continue the clinical trial without modification of the current protocol, based on the pre-planned review of safety data.
The recommendation was based on the unblinded review by the DMC of safety data from more than 900 patients randomized in t...
No comment yet